EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Top Biotech Stocks To Watch Today - July 18th - Stock Observer
Immune correlates of risk for SARS-CoV-2 infection in children: a prospective, community-based cohort study
Best Biotech Stocks To Consider - July 17th - Zolmax
Three Seasons Wealth LLC Acquires Shares of 8,016 Moderna, Inc. $MRNA
BMJ Senior Editor: COVID vaccines more likely to put you in hospital than keep you out
Moderna (MRNA) Stock Looks Stretched On Sales But Reasonable On Momentum
Sanofi launches mRNA vaccine lawsuits at Moderna and Pfizer
Sanofi launches mRNA lawsuits on Moderna and Pfizer
Pfizer says vaccine is 100% effective in protecting adolescents
Global Vaccine Sales Market to Reach US$141.40 Billion by 2036 as Next-Generation Platforms Accelerate Growth
MRNA: Flu Approval Uncertainty And Delayed Vaccine Revenues Will Restrain Upside
Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks
Y Intercept Hong Kong Ltd Sells 444,343 Shares of Moderna, Inc. $MRNA
US Stock Market Today: S&P 500 Futures Climb On Cooler Global Inflation And Yields
The Ugandan city where the race for a new Ebola vaccine will be won or lost
Moderna (MRNA) Faces A Fresh Valuation Test Following Its Flu Vaccine Decision
Moderna, Inc. (NASDAQ:MRNA) Receives Average Recommendation of "Reduce" from Brokerages - Daily Political
Moderna (MRNA) Stock Plunges Over 10% Amid Insider Sales and Bearish Analyst Sentiment
Does Moderna's (MRNA) New Board Appointment Hint At A Shift In Capital Allocation Priorities?
Moderna Sees Unusually High Options Volume (NASDAQ:MRNA)
Moderna Drops 11%, ImmunityBio and Sarepta Therapeutics Tumble 8% in Biotech Rout
QRG Capital Management Inc. Acquires New Stake in Moderna, Inc. $MRNA
Why Moderna (MRNA) Stock Is Trading Up Today
Fendi Fall 2026 Haute Couture Runway, Fashion Show & Collection Review
Moderna wins EU contract for RSV vaccine supply
RBC Capital Raises its Price Target on Moderna (MRNA)
Moderna (MRNA) Settles Vaccine Patent Case With $950 Million Upfront Payment
10 Best Performing American Stocks in June 2026
Biotech Stocks To Add to Your Watchlist - July 6th - Markets Daily
Moderna (MRNA) Stock Surges 169% Despite Wall Street Skepticism
Biotech Stocks To Add to Your Watchlist - July 6th - Stock Observer
Medical Stocks To Add to Your Watchlist - July 6th - Daily Political
17,700 Shares in Moderna, Inc. $MRNA Bought by Louisiana State Employees Retirement System
Real-world effectiveness and impact of the 4CMenB vaccine against serogroup B invasive meningococcal disease: a systematic review and meta-analysis
Biotech Stocks To Watch Now - July 4th - Zolmax
Jim Cramer Says "For the First Time in Ages, I Like Having a Position in Moderna"
Tesla, Rivian, Strategy, Moderna, Sandisk, Blue Owl, and More Stocks That Explain Today's Market
Moderna (NASDAQ:MRNA) Hits New 12-Month High - Here's Why - Daily Political
Breaking: Moderna's mRNA Flu Vaccine Gets Unanimous Thumbs-Up Despite Risks, Low Efficacy
Jim Cramer says this former Covid market darling is finally investable again
Moderna (MRNA) Is Up 14.8% After FDA Panel Backs mRNA Flu Shot mFlusiva Approval - Has The Bull Case Changed?
Promising Biotech Stocks To Follow Now - July 1st - Daily Political
mRNA Cancer Vaccine Market to Surpass $1.20 Billion in 2026 as Personalized Oncology Immunotherapies Advance, New Report Finds
Safety and immunogenicity of concomitant quadrivalent meningococcus ACYW-TT and meningococcus group B vaccines
Therapeutics Stocks Q1 Recap: Benchmarking Vertex Pharmaceuticals (NASDAQ:VRTX)
Spotting Winners: Myriad Genetics (NASDAQ:MYGN) And Therapeutics Stocks In Q1
Pharma-Funded Campaign Silenced Online Vaccine Dissent, Documents Reveal - NaturalNews.com
Promising Biotech Stocks To Watch Today - June 29th - Markets Daily
Moderna (MRNA) Stock Soars 13% on Groundbreaking CAR-T Program Announcement
US Stock Market Today: S&P 500 Futures Slip On Sticky Inflation And Trade Concerns
Sensex Today | Stock Market Live: GIFT Nifty indicates a muted start; Asia, US markets mixed
Top Biotech Stocks To Keep An Eye On - June 28th - Stock Observer
Moderna Stock and Healthcare Names Facing the Biggest Regulatory Calls
Promising Biotech Stocks To Keep An Eye On - June 27th - Stock Observer
SG Americas Securities LLC Sells 27,930 Shares of Moderna, Inc. $MRNA
SG Americas Securities LLC Lowers Stock Holdings in Moderna, Inc. $MRNA - Daily Political
Intranasal boosting induces variant-specific responses in SARS-CoV-2 vaccine-imprinted mice
S&P 500 ends lower; chips tumble and Moderna rallies
Healthcare stocks have become a haven for investors ditching tech | Morningstar
Why Moderna (MRNA) Stock Is Soaring Today - June 26, 2026
Moderna Gains 11% As Science Day Highlights Expanding MRNA Pipeline
Moderna (NASDAQ:MRNA) Reaches New 12-Month High - Here's Why - Zolmax
Stocks making the biggest moves midday: MRNA, ON, RKLB, LLY, SNDK
Moderna Is Up 13% Today: Is It Outperforming Other Vaccine Stocks Like Merck and Pfizer?
Moderna enters in vivo CAR-T, granting autoimmune asset '007' license to kill pathogenic cells | Fierce Biotech
Moderna (NASDAQ:MRNA) Reaches New 12-Month High - Here's Why - Daily Political
Moderna Upbeat on New Flu Shot to Help Educate Public About MRNA
Friedenthal Financial Invests $1.10 Million in Moderna, Inc. $MRNA
Hsbc Holdings PLC Sells 107,077 Shares of Moderna, Inc. $MRNA
Moderna (MRNA) Is Up 10.1% After Unanimous FDA Panel Backing For mRNA Flu Shot mFlusiva
Therapeutics Stocks Q1 Recap: Benchmarking Biogen (NASDAQ:BIIB)
RNA Therapeutics Market Set to Nearly Triple by 2034 as Regulatory Approvals and Pandemic Preparedness Drive Adoption
Moderna (MRNA) Stock Could Be 39% Overvalued After FDA Flu Vaccine Backing
Biotech Stocks Worth Watching - June 21st
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Moderna (MRNA)
Analysts Conflicted on These Healthcare Names: AbbVie (ABBV) and Moderna (MRNA)
Moderna (MRNA) Receives Unanimous FDA Panel Support for Flu Vaccine
Dianthus Therapeutics (NASDAQ:DNTH) vs. Moderna (NASDAQ:MRNA) Financial Analysis - Markets Daily
Moderna, Inc. (NASDAQ:MRNA) Given Consensus Rating of "Reduce" by Analysts - Zolmax
What Roivant Sciences (ROIV)'s $2.25 Billion Moderna Settlement and Immunology Wins Mean For Shareholders - Simply Wall St News
Moderna, Inc. $MRNA Shares Sold by Tobam
Promising Biotech Stocks To Follow Today - June 19th - Stock Observer
Roivant Sciences (ROIV) Stock Could Be 19.5% Undervalued After Moderna Settlement And Pipeline Progress
Hamilton Wealth LLC Acquires New Stake in Moderna, Inc. $MRNA
Stephen Hoge Sells 53,336 Shares of Moderna (NASDAQ:MRNA) Stock - Markets Daily
FDA Advisors Support Moderna's mRNA Flu Vaccine for Adults 50 and Older, ETPharma
FDA committee recommends a new mRNA flu vaccine : NPR
FDA panel recommends mRNA flu vaccine for older adults
Healthcare Stocks Fall on Hawkish Fed Turn - Healthcare Roundup | Morningstar
Latest news
Show more
Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty
September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations
Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge
